Replies to post #696423 on NorthWest Biotherapeutics Inc (NWBO)

[vator]

I would bet they could have procured a loan for that much. Instead this company took equity. The added benefit is they do actual analysis for the markets. It benefits NWBO to start getting coverage. With this act we may start to finally see participation at investment conferences. Wouldn’t that be a change?

[Chiugray]

XMaster, Given the tentative manipulated low stock price, $3M is probably the smallest equity round size NWBO could do when bringing on a new money institutional fund. It is smart financial strategy to start lining up supportive long term financial investors, especially now and if they have researchers and analysts on their team. $3M corresponds roughly to about a month's cash burn for operations. Maybe that is in anticipation for June being the pivotal DCVax approval month. When they go on to negotiating a next financing, post approval, it is better to already have existing investors that are institutions.